STOCK TITAN
  1. Home
  2. News
  3. OGI

Organigram Holdings Inc. Common Shares - OGI STOCK NEWS

Welcome to our dedicated page for Organigram Holdings Common Shares news (Ticker: OGI), a resource for investors and traders seeking the latest updates and insights on Organigram Holdings Common Shares stock.

OrganiGram Holdings Inc. (symbol: OGI) is a leading licensed producer of cannabis, based in Atlantic Canada. As part of Canada’s Marihuana for Medical Purposes Regulations (MMPR), OrganiGram specializes in the cultivation of high-quality, organically grown medical marijuana. The company is committed to providing the best possible medicine and service to its clients.

OrganiGram’s primary operations revolve around the production of indoor-grown cannabis for both medical patients and adult recreational users in Canada. The company has built a diverse portfolio of adult-use recreational cannabis brands including Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, and Trailblazer. Recently, Organigram has expanded its brand lineup with the addition of Tremblant Cannabis and the artisanal craft brand, Laurentian.

OrganiGram has garnered recognition for its innovative and high-quality cannabis products. The company places a strong emphasis on research and development to continually improve its cultivation techniques and product offerings. OrganiGram has also established significant partnerships which support its growth and expansion plans.

Financially, OrganiGram has shown resilience and adaptability in a competitive market. The company regularly updates investors and stakeholders with the latest developments and financial results, ensuring transparency and fostering trust.

OrganiGram Holdings Inc. is dedicated to advancing the cannabis industry through sustainable practices and a commitment to quality. For more information or inquiries, visit www.organigram.ca or contact their client services team at 1-855-961-9420.

News

Organigram Launches First Range of THCV Products Derived from Moncton-Grown Whole Flower

Rhea-AI Summary
Organigram launches its first range of THCV products through its SHRED and Trailblazer brands, thanks to its strategic investment in Phylos Bioscience. Organigram is the only Canadian licensed producer to cultivate and extract THCV in-house. THCV is gaining popularity for its appetite suppressing effects and non-psychoactive properties. Organigram has exclusive Canadian rights to high-THCV cultivars from Phylos. The company's THCV products include SHRED'ems Guava Lime Go-Time and Trailblazer Zen Garden Grapefruit, offering unique cannabinoid experiences with high THC:THCV ratios.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.88%
Tags
none
-
News

Organigram Relaunches one of Canada’s First Cannabis Brands, Trailblazer

Rhea-AI Summary
Organigram relaunches Trailblazer brand with new product lineup targeting a $1.2B segment of the cannabis market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.1%
Tags
none
-
News

Organigram to Enter the United Kingdom with Agreement to Supply Medical Cannabis to 4C LABS

Rhea-AI Summary
Organigram has entered into a supply agreement with 4C LABS to provide dried Medical Cannabis flower to the UK market. The agreement is expected to reach approximately 600 kilograms of high-margin Medical Cannabis flower in the first year, with increasing targets in the following years. Organigram will also grant limited strain exclusivity to cultivars distributed by 4C LABS. This expands Organigram's international supply agreements, reflecting their strategy to expand beyond Canada into international markets.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.94%
Tags
none
News

Organigram’s Application for Judicial Review on Jolts Ingestible Extract Granted

Rhea-AI Summary
Organigram Holdings Inc. has been granted a judicial review by the Federal Court of Canada regarding Health Canada's classification of their Edison Jolts lozenges as edible cannabis. The Court found a breach of procedural fairness and the matter is being sent back to Health Canada for reconsideration. Organigram is pleased with the outcome and looks forward to further review of their ingestible extract.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.73%
Tags
none
-
News

Organigram Launches New Tube-style Pre-rolls: SHRED Dartz and Holy Smokes

Rhea-AI Summary
Organigram Holdings Inc. has launched new tube-style pre-rolls, SHRED Dartz and Holy Smokes, in response to the growing demand for this format in the cannabis market. These pre-rolls are expected to capture a significant share of the expanding tube-style pre-roll category. Each box contains ten 0.4g pre-rolls and offers unique blends and strain-specific options. The products are rolled with 100% organic hemp paper, providing a more natural and elevated cannabis experience.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.7%
Tags
none
-
News

Organigram Reports Third Quarter Fiscal 2023 Results

Rhea-AI Summary
Organigram Holdings Inc. announced its Q3 Fiscal 2023 results, reporting a 14% decrease in net revenue compared to the prior period. The company regained the #3 position in the Canadian market and achieved strong sales in milled flower, concentrates, and gummies. They also made strategic investments in Phylos and Greentank. Organigram's international sales for the first nine months of fiscal 2023 exceeded the prior year by 94%. They have a strong balance sheet with $75 million in cash and negligible debt.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-19.59%
Tags
earnings
News

Organigram to Report Third Quarter Fiscal 2023 Results on July 13, 2023

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.63%
Tags
conferences earnings
-
News

Organigram Introduces Ultra High-THC Infused Pre-Rolls, SHRED X Heavies

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.24%
Tags
none
-
News

Organigram Announces Effective Date of Share Consolidation

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.59%
Tags
none
News

Organigram Makes First Strategic U.S. Investment in Phylos Bioscience to Commercialize THCV and Scale Seed Based Production

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.12%
Tags
none

FAQ

What is the current stock price of Organigram Holdings Common Shares (OGI)?

The current stock price of Organigram Holdings Common Shares (OGI) is $1.57 as of January 10, 2025.

What is the market cap of Organigram Holdings Common Shares (OGI)?

The market cap of Organigram Holdings Common Shares (OGI) is approximately 198.1M.

What is OrganiGram Holdings Inc.?

OrganiGram Holdings Inc. is a Canadian company engaged in the production of indoor-grown cannabis for medical patients and adult recreational users.

What types of cannabis products does OrganiGram offer?

OrganiGram offers a range of cannabis products under brands such as Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, Trailblazer, Tremblant Cannabis, and Laurentian.

Where is OrganiGram Holdings Inc. based?

OrganiGram Holdings Inc. is based in Atlantic Canada.

How can I contact OrganiGram's client services team?

You can contact OrganiGram's client services team by calling 1-855-961-9420.

Is OrganiGram involved in research and development?

Yes, OrganiGram places a strong emphasis on research and development to enhance its cultivation techniques and product offerings.

What regulations does OrganiGram operate under?

OrganiGram operates under Canada’s Marihuana for Medical Purposes Regulations (MMPR).

Is OrganiGram Holdings Inc. publicly traded?

Yes, OrganiGram Holdings Inc. is publicly traded under the symbol OGI.

Where can I find more information about OrganiGram?

You can find more information about OrganiGram by visiting their website at www.organigram.ca.

What makes OrganiGram's cannabis products unique?

OrganiGram's cannabis products are unique due to their high quality, organically grown nature, and diverse brand portfolio.

Has OrganiGram recently expanded its product lineup?

Yes, OrganiGram has recently added Tremblant Cannabis and the artisanal craft brand, Laurentian to its product lineup.
Stock OGI logo
Organigram Holdings Inc. Common Shares

Nasdaq:OGI

OGI Rankings

#3896 Ranked by Market Cap
N/A Ranked by Dividends

OGI Stock Data

198.07M
93.38M
34.27%
9.71%
2.41%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Toronto